Feedback / Questions
MB-105 - March Bio
https://www.globenewswire.com/news-release/2025/12/08/3201704/0/en/March-Biosciences-Presents-Positive-Interim-Clinical-Data-from-Phase-2-Trial-of-MB-105-CD5-CAR-T-Cell-Therapy-at-ASH-2025-Annual-Meeting.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next